文献速递湿疹皮炎与荨麻疹

特应性皮炎患者结膜炎:国际湿疹理事会调查与意见

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-05-06

共识建议 AD 患者应常规询问眼部症状、启动 dupilumab 前告知结膜炎风险,新发结膜炎时尽可能继续 dupilumab 并转诊眼科。

要点

  • AD患者应常规询问眼部不适或症状。
  • 启动dupilumab前应告知结膜炎潜在风险。
  • 新发结膜炎时尽可能继续dupilumab并转诊眼科。

核心结论

  • IEC建议皮肤科医生关注AD患者结膜炎,尤其在dupilumab治疗期间。

主要发现

  • 对诊断检查、转诊和治疗等若干陈述达成共识。

关键数值与推荐

  • AD患者应常规询问眼部不适或症状。
  • 启动dupilumab前应获取结膜炎潜在风险信息。
  • 如有指征,即使既往或当前有结膜炎也应使用dupilumab治疗。
  • 新发结膜炎时,共识认为尽可能继续dupilumab并适当转诊眼科。

临床怎么用

  • 皮肤科医生应主动评估AD患者结膜炎,dupilumab治疗期间尤其注意。

局限性

  • 研究依赖皮肤科专家的意见。
  • 未排除无dupilumab使用经验的皮肤科医生的回答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Conjunctivitis is common in patients with atopic dermatitis (AD) in general and a commonly reported adverse event in AD clinical trials with dupilumab. OBJECTIVE: To survey opinions and experience about conjunctivitis occurring in AD, including those during dupilumab treatment in a group of AD experts from the International Eczema Council (IEC). METHODS: Electronic survey and in-person discussion of management strategies. RESULTS: Forty-six (53.5%) IEC members from 19 countries responded to the survey. Consensus was reached for several statements regarding diagnostic workup, referral and treatment. IEC members suggest that patients with AD should (i) routinely be asked about ocular complaints or symptoms, (ii) obtain information about the potential for conjunctivitis before starting dupilumab therapy and (iii) if indicated, be treated with dupilumab despite previous or current conjunctivitis. In cases of new-onset conjunctivitis, there was consensus that dupilumab treatment should be continued when possible, with appropriate referral to an ophthalmologist. LIMITATIONS: The study relies on expert opinion from dermatologists. Responses from few dermatologists without dupilumab access were not excluded from the survey. CONCLUSION: The IEC recommends that dermatologists address conjunctivitis in patients with AD, especially during treatment with dupilumab.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Thyssen JP, de Bruin-Weller MS, Paller AS, et al. Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion. J Eur Acad Dermatol Venereol. 2019. PMID: 31056788. doi:10.1111/jdv.15608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。